|1.||Gimeno, Mercedes: 1 article (08/2006)|
|2.||Ponte, Carmen: 1 article (08/2006)|
|3.||Rodríguez-Cerrato, Violeta: 1 article (08/2006)|
|4.||Soriano, Francisco: 1 article (08/2006)|
|5.||Gracia, Matilde: 1 article (08/2006)|
|6.||Coronel, Pilar: 1 article (08/2006)|
|7.||Huelves, Lorena: 1 article (08/2006)|
|8.||Del Prado, Gema: 1 article (08/2006)|
|9.||Martínez-Marín, Carmina: 1 article (08/2006)|
|10.||Blanco, Jorge: 1 article (08/2006)|
05/01/1985 - "The study was done to evaluate the usefulness of cefminox (CMNX, MT-141) injection for the treatment of infections in the field of obstetrics and gynecology. "
03/01/1985 - "Fundamental and clinical trials were carried out with cefminox (CMNX, MT-141) in pediatric infections. "
09/01/2000 - "Cefminox is as effective and as safe as M+G in the treatment of intra-abdominal infections."
06/01/1985 - "[Treatment of severe infection in patients with hematological disorders by cefminox. "
05/01/1985 - "Cefminox (CMNX, MT-141) was used in the treatment of obstetrical and gynecological infections with following results. "
|2.||Urinary Tract Infections (Urinary Tract Infection)
01/01/1985 - "Effects of MT-141, a new cephamycin antibiotic, on acute urinary tract infections."
09/01/1995 - "[Cefminox versus cefotaxime in the treatment of complicated urinary tract infection]."
01/01/1985 - "To assess the rapid bactericidal properties of MT-141, a new cephamycin antibiotic, bacteriological response to MT-141 and latamoxef was compared in complicated urinary tract infections. "
01/01/1985 - "Comparison of rapid bacteriological response to MT-141 and latamoxef in complicated urinary tract infections."
01/01/1985 - "The bacteriological efficacy of MT-141, a new cephamycin antibiotic, was compared with that of cefotaxime and latamoxef in women with acute simple urinary tract infections, to assess the rapid bactericidal properties of MT-141. "
05/01/1985 - "[Cefminox concentration in tissues and clinical efficacy of cefminox in acute peritonitis]."
10/01/1990 - "[Investigation on clinical efficacy and passage into ascites of cefminox in diffuse peritonitis associated with infantile acute appendicitis]."
05/01/1985 - "Cefminox (CMNX, MT-141) was studied both fundamentally and clinically with following results: In the treatment of 3 cases of Bartholin's abscess, 2 cases of pyometra, and 1 case each of bartholinitis, inflammation of the pelvic dead space, retroperitoneal abscess and pelvic peritonitis, CMNX was administered at a dosage of 1 g. "
10/01/1990 - "Cefminox (CMNX), one of newly developed cephamycin antibiotics, was administered to 7 cases of diffuse peritonitis associated with infantile acute appendicitis to determine its concentrations in the blood, the appendiceal tissue and the purulent ascites and simultaneously to investigate its clinical efficacy. "
12/01/1999 - "Cefminox has proved to be 4-16 times more active than cefoxitin against enteric Gram-negative bacilli commonly involved in cholecystitis, secondary peritonitis, intraabdominal abscesses and gynecological infections. "
|4.||Bacterial Infections (Bacterial Infection)
01/01/1990 - "Efficacy of cefminox in the treatment of bacterial infections."
03/01/1985 - "A new antibiotic of cephamycin group, cefminox (CMNX, MT-141), was evaluated clinically in the treatment of bacterial infections in children. "
03/01/1985 - "Cefminox (CMNX, MT-141) was given intravenously to 20 children with the following acute bacterial infections; 10 cases of bronchopneumonia, 4 cases of urinary tract infection, 2 cases of staphylococcal scalded skin syndrome, each 1 case of acute pharyngitis, acute tonsillitis, purulent cervical lymphadenitis and acute tonsillitis, and pleuritis. "
|3.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
|4.||Anti-Bacterial Agents (Antibiotics)
|4.||Lymph Node Excision (Lymph Node Dissection)